Dxn EBIT per Employee
The EBIT per Employee of Dxn (DXN.AX) as of Jul 22, 2026 is -33,140.00 AUD. In the previous year, EBIT per Employee was -26,723.33 AUD — a change of 24.01% (lower).
Get this data via API
Financial Data API
EBIT per Employee
-33,140.00AUD
YoY
24.01%
Last updated:
EBIT per Employee of Dxn is 2026 -33,140.00 AUD. EBIT per Employee of Dxn was 2025 -26,723.33 AUD. It decreases by 24.01% lower compared to the previous year.
Access this data via the Eulerpool API
Dxn Stock analysis
What does Dxn do? DXN Ltd is a leading global company in the health and wellness industry, headquartered in Malaysia. The company was founded in 1993 by Dato' Dr. Lim Siow Jin, who developed a revolutionary business model to offer high-quality dietary supplements and healthy beverages. The goal was to enable people worldwide to have a better and healthier life.
The history of DXN Ltd began over 25 years ago when Dato' Dr. Lim Siow Jin discovered his passion for herbal medicine and started researching medicinal mushrooms. Initially, it was difficult to garner people's interest in herbal medicine. However, over time, the company became increasingly successful and interest in its products grew.
DXN Ltd has developed a unique business model that allows people to build a business in the health and wellness industry while selling healthy products. DXN refers to this as the "One Dragon, One World, One Market" concept. This means that DXN focuses on selling products based on natural ingredients and markets them through a network of distributors worldwide.
DXN Ltd offers various product lines. One of its most well-known products is "Lingzhi Coffee," which is made from natural ingredients and contains all the benefits of "Lingzhi," a medicinal mushroom. The company also offers other coffee varieties, tea, dietary supplements, and skincare products.
The dietary supplements offered by DXN Ltd are based on natural ingredients such as mushrooms and herbs. Each product is carefully manufactured and tested to ensure the highest quality. DXN Ltd has received many patents for its products and is known for its innovative offerings.
The company also provides a comprehensive training program for its distributors to ensure that they understand the products and the business model and can market them successfully. DXN Ltd has built a global network of distributors registered in over 180 countries.
DXN Ltd has received many awards for its products and business model. It has been named "Company of the Year" by Direct Selling News Magazine and has also received the "Reader's Digest Asia Trusted Brand Award" for its outstanding products and services.
DXN Ltd is committed to continued growth and expanding its range of healthy products. The company also actively promotes environmental protection and engages in various charitable activities to give back to society.
In summary, DXN Ltd is an innovative and future-oriented company dedicated to promoting a healthy and better life for people worldwide. With its high-quality products and unique business model, the company has achieved a strong position in the health and wellness industry. Dxn is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Dxn stock
EBIT per Employee of Dxn is -33,140.00 AUD in 2026.
Access this data via the Eulerpool API
Workforce — Dxn
All Key Metrics — Dxn
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth